GSK (GSK) News Today $36.62 -0.34 (-0.91%) Closing price 03:59 PM EasternExtended Trading$36.50 -0.12 (-0.34%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSKFebruary 21 at 1:50 PM | globenewswire.comGSK plc Class Action: Levi & Korsinsky Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSKFebruary 21 at 5:45 AM | prnewswire.comDown 21% from May despite excellent Q4 2024 results, is GSK’s share price an irresistible bargain to me now?February 21 at 4:37 AM | uk.finance.yahoo.comGSK’s Beaten-Down Shares Seen at Risk of New Activist CampaignFebruary 21 at 4:37 AM | bloomberg.comD.A. Davidson & CO. Decreases Position in GSK plc (NYSE:GSK)D.A. Davidson & CO. trimmed its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 14.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 87,847 shares of the pharmaceutical company's stock afterFebruary 21 at 4:09 AM | marketbeat.comThe Gross Law Firm Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline – GSKFebruary 20 at 1:34 PM | globenewswire.comContact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)February 20 at 5:45 AM | prnewswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKFebruary 19 at 6:32 PM | globenewswire.comCanada purchases 500,000 doses of GSK's vaccine for bird fluFebruary 19 at 1:09 PM | reuters.comGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitFebruary 19 at 12:00 PM | prnewswire.comSanctuary Advisors LLC Reduces Stake in GSK plc (NYSE:GSK)Sanctuary Advisors LLC decreased its stake in shares of GSK plc (NYSE:GSK - Free Report) by 6.8% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 254,072 shares of the pharmaceutical company's stock after selling 18,488 shares during theFebruary 19 at 4:48 AM | marketbeat.comAmericana Partners LLC Decreases Stock Holdings in GSK plc (NYSE:GSK)Americana Partners LLC decreased its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 74.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,302 shares of the pharmaceutical company's stocFebruary 19 at 4:31 AM | marketbeat.comGSK Investors Have Opportunity to Lead GSK plc Securities Fraud LawsuitFebruary 18 at 8:06 PM | prnewswire.comShareholders that lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSKFebruary 18 at 2:27 PM | globenewswire.comGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitFebruary 18 at 12:00 PM | prnewswire.comGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law FirmFebruary 18 at 9:27 AM | prnewswire.comKeating Investment Counselors Inc. Invests $5.53 Million in GSK plc (NYSE:GSK)Keating Investment Counselors Inc. acquired a new position in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 163,605 shares of the pharmaceutical company's stock, valued at approximatelFebruary 18 at 6:09 AM | marketbeat.comKornitzer Capital Management Inc. KS Has $11.71 Million Stake in GSK plc (NYSE:GSK)Kornitzer Capital Management Inc. KS trimmed its position in shares of GSK plc (NYSE:GSK - Free Report) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 346,293 shares of the pharmaceutical company's stock afterFebruary 18 at 5:52 AM | marketbeat.comGSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSKFebruary 18 at 5:45 AM | prnewswire.comJFS Wealth Advisors LLC Has $120,000 Stock Position in GSK plc (NYSE:GSK)JFS Wealth Advisors LLC cut its position in GSK plc (NYSE:GSK - Free Report) by 87.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,561 shares of the pharmaceutical company's stock after selling 25,865 shares duringFebruary 18 at 4:40 AM | marketbeat.comGSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'February 18 at 3:01 AM | seekingalpha.comGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with ...February 17, 2025 | gurufocus.comKen Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for InvestorsFebruary 17, 2025 | benzinga.comStrategic Financial Concepts LLC Takes Position in GSK plc (NYSE:GSK)Strategic Financial Concepts LLC acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 119,236 shares of the pharmaceutical company's stFebruary 17, 2025 | marketbeat.comLegacy Capital Wealth Partners LLC Sells 23,681 Shares of GSK plc (NYSE:GSK)Legacy Capital Wealth Partners LLC cut its position in shares of GSK plc (NYSE:GSK - Free Report) by 59.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,088 shares of the pharmaceutical company's sFebruary 17, 2025 | marketbeat.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKFebruary 16, 2025 | investing.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before ...February 16, 2025 | gurufocus.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKFebruary 16, 2025 | globenewswire.comGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with ...February 16, 2025 | gurufocus.comGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 16, 2025 | prnewswire.comGSK plc (NYSE:GSK) Position Reduced by Yousif Capital Management LLCYousif Capital Management LLC reduced its stake in GSK plc (NYSE:GSK - Free Report) by 24.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,806 shares of the pharmaceutical company's stock after sellingFebruary 16, 2025 | marketbeat.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKFebruary 15, 2025 | investing.comFigure 8 Investment Strategies LLC Buys New Position in GSK plc (NYSE:GSK)Figure 8 Investment Strategies LLC purchased a new position in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 14,456 shares of the pharmaceutical company's stock, vaFebruary 15, 2025 | marketbeat.comVan ECK Associates Corp Acquires 107,529 Shares of GSK plc (NYSE:GSK)Van ECK Associates Corp raised its position in GSK plc (NYSE:GSK - Free Report) by 14.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 844,039 shares of the pharmaceutical company's stock after buying anFebruary 15, 2025 | marketbeat.comHere’s the dividend forecast for GSK shares through to 2026!February 15, 2025 | msn.comGSK (NYSE:GSK) Coverage Initiated at Morgan StanleyFebruary 15, 2025 | americanbankingnews.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKFebruary 14, 2025 | investing.comUS FDA approves GSK's combo meningococcal vaccineFebruary 14, 2025 | reuters.comShareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class ActionFebruary 14, 2025 | prnewswire.comGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 14, 2025 | globenewswire.comHedge Fund Citadel takes short position in GSK, FT reportsFebruary 14, 2025 | reuters.comIndia's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugsFebruary 14, 2025 | reuters.comShareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSKFebruary 14, 2025 | prnewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKFebruary 14, 2025 | markets.businessinsider.comIngalls & Snyder LLC Reduces Position in GSK plc (NYSE:GSK)Ingalls & Snyder LLC cut its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 30.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,315 shares of the pharmaceutical company's stock after selling 8,340February 14, 2025 | marketbeat.comEmpowered Funds LLC Invests $2.62 Million in GSK plc (NYSE:GSK)Empowered Funds LLC bought a new position in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 77,576 shares of the pharmaceutical company's stock, valued at approximaFebruary 14, 2025 | marketbeat.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKFebruary 13, 2025 | globenewswire.comGSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – GSKFebruary 13, 2025 | globenewswire.comGSK Executives Acquire Shares Under Reward PlanFebruary 13, 2025 | tipranks.comClass Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact The Gross Law FirmFebruary 13, 2025 | prnewswire.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.380.60▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼3913▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
